BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 24797827)

  • 21. Mesenchymal cells from human amniotic fluid survive and migrate after transplantation into adult rat brain.
    Cipriani S; Bonini D; Marchina E; Balgkouranidou I; Caimi L; Grassi Zucconi G; Barlati S
    Cell Biol Int; 2007 Aug; 31(8):845-50. PubMed ID: 17379545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kidney graft outcome using an anti-Xa therapeutic strategy in an experimental model of severe ischaemia-reperfusion injury.
    Tillet S; Giraud S; Delpech PO; Thuillier R; Ameteau V; Goujon JM; Renelier B; Macchi L; Hauet T; Mauco G
    Br J Surg; 2015 Jan; 102(1):132-42; discussion 142. PubMed ID: 25402331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intra renal arterial injection of autologous mesenchymal stem cells in an ovine model in the postischemic kidney.
    Behr L; Hekmati M; Fromont G; Borenstein N; Noel LH; Lelievre-Pegorier M; Laborde K
    Nephron Physiol; 2007; 107(3):p65-76. PubMed ID: 17940346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stem cells derived from human amniotic fluid contribute to acute kidney injury recovery.
    Hauser PV; De Fazio R; Bruno S; Sdei S; Grange C; Bussolati B; Benedetto C; Camussi G
    Am J Pathol; 2010 Oct; 177(4):2011-21. PubMed ID: 20724594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HB-EGF augments the ability of mesenchymal stem cells to attenuate intestinal injury.
    Watkins DJ; Zhou Y; Matthews MA; Chen L; Besner GE
    J Pediatr Surg; 2014 Jun; 49(6):938-44; discussion 944. PubMed ID: 24888839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Marrow Mesenchymal Stem Cells Effectively Reduce Histologic Changes in a Rat Model of Chronic Renal Allograft Rejection.
    Yu P; Wang Z; Liu Y; Xiao Z; Guo Y; Li M; Zhao M
    Transplant Proc; 2017 Nov; 49(9):2194-2203. PubMed ID: 29149982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stem cells from amniotic fluid--Potential for regenerative medicine.
    Loukogeorgakis SP; De Coppi P
    Best Pract Res Clin Obstet Gynaecol; 2016 Feb; 31():45-57. PubMed ID: 26542929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multipotent mesenchymal stem cells from amniotic fluid originate neural precursors with functional voltage-gated sodium channels.
    Mareschi K; Rustichelli D; Comunanza V; De Fazio R; Cravero C; Morterra G; Martinoglio B; Medico E; Carbone E; Benedetto C; Fagioli F
    Cytotherapy; 2009; 11(5):534-47. PubMed ID: 19548144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraparenchymal injection of bone marrow mesenchymal stem cells reduces kidney fibrosis after ischemia-reperfusion in cyclosporine-immunosuppressed rats.
    Alfarano C; Roubeix C; Chaaya R; Ceccaldi C; Calise D; Mias C; Cussac D; Bascands JL; Parini A
    Cell Transplant; 2012; 21(9):2009-19. PubMed ID: 22525800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization, GFP gene Nucleofection, and allotransplantation in injured tendons of ovine amniotic fluid-derived stem cells.
    Colosimo A; Curini V; Russo V; Mauro A; Bernabò N; Marchisio M; Alfonsi M; Muttini A; Mattioli M; Barboni B
    Cell Transplant; 2013; 22(1):99-117. PubMed ID: 22507078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study.
    Reinders ME; de Fijter JW; Roelofs H; Bajema IM; de Vries DK; Schaapherder AF; Claas FH; van Miert PP; Roelen DL; van Kooten C; Fibbe WE; Rabelink TJ
    Stem Cells Transl Med; 2013 Feb; 2(2):107-11. PubMed ID: 23349326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postconditioning effects of argon or xenon on early graft function in a porcine model of kidney autotransplantation.
    De Deken J; Rex S; Lerut E; Martinet W; Monbaliu D; Pirenne J; Jochmans I
    Br J Surg; 2018 Jul; 105(8):1051-1060. PubMed ID: 29603122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.
    Huang J; Zhang Z; Guo J; Ni A; Deb A; Zhang L; Mirotsou M; Pratt RE; Dzau VJ
    Circ Res; 2010 Jun; 106(11):1753-62. PubMed ID: 20378860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Injection of amniotic fluid stem cells delays progression of renal fibrosis.
    Sedrakyan S; Da Sacco S; Milanesi A; Shiri L; Petrosyan A; Varimezova R; Warburton D; Lemley KV; De Filippo RE; Perin L
    J Am Soc Nephrol; 2012 Apr; 23(4):661-73. PubMed ID: 22302195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infusion of mesenchymal stem cells protects lung transplants from cold ischemia-reperfusion injury in mice.
    Tian W; Liu Y; Zhang B; Dai X; Li G; Li X; Zhang Z; Du C; Wang H
    Lung; 2015 Feb; 193(1):85-95. PubMed ID: 25344633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis.
    Xiang E; Han B; Zhang Q; Rao W; Wang Z; Chang C; Zhang Y; Tu C; Li C; Wu D
    Stem Cell Res Ther; 2020 Aug; 11(1):336. PubMed ID: 32746936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesenchymal stem cell-derived extracellular vesicles attenuate kidney inflammation.
    Eirin A; Zhu XY; Puranik AS; Tang H; McGurren KA; van Wijnen AJ; Lerman A; Lerman LO
    Kidney Int; 2017 Jul; 92(1):114-124. PubMed ID: 28242034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic potential of a distinct population of human amniotic fluid mesenchymal stem cells and their secreted molecules in mice with acute hepatic failure.
    Zagoura DS; Roubelakis MG; Bitsika V; Trohatou O; Pappa KI; Kapelouzou A; Antsaklis A; Anagnou NP
    Gut; 2012 Jun; 61(6):894-906. PubMed ID: 21997562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nestin(+) kidney resident mesenchymal stem cells for the treatment of acute kidney ischemia injury.
    Jiang MH; Li G; Liu J; Liu L; Wu B; Huang W; He W; Deng C; Wang D; Li C; Lahn BT; Shi C; Xiang AP
    Biomaterials; 2015 May; 50():56-66. PubMed ID: 25736496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesenchymal Stem Cells from Wharton's Jelly and Amniotic Fluid.
    Joerger-Messerli MS; Marx C; Oppliger B; Mueller M; Surbek DV; Schoeberlein A
    Best Pract Res Clin Obstet Gynaecol; 2016 Feb; 31():30-44. PubMed ID: 26482184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.